Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Q2 2020 Bio-Techne Corp Earnings Call Transcript

Feb 04, 2020 / 02:00PM GMT
Release Date Price: €44.75 (-5.79%)
Operator

Good morning, and welcome to the Bio-Techne Earnings Conference call for the Second Quarter of Fiscal Year 2020. (Operator Instructions) I would now like to turn the call over to Mr. David Clair, Bio-Techne's Senior Director, Corporate Development.

David Clair
Bio-Techne Corporation - Senior Director of Corporate Development

Good morning, and thank you for joining us. On the call with me this morning are Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne. Before we begin, let me briefly cover our safe harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company's future results.

The company's 10-K for fiscal year 2019 identify certain factors that could cause the company's actual results to differ materially from those projected in the forward-looking statements made during this call. The company does not undertake to update any forward-looking statements as a result of any new information or future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot